subscription packs

Health News

A new Thyroid drug charged with increasing toxicity in patients

 Astra Zeneca is soon going to bring to the market a new drug “Vendetanib”. The drug Vendetanib is supposed to act as a curative agent in patients with Thyroid Cancer. Astra Zeneca has submitted an application with the FDA, USA to the same effect. But the FDA has expressed concerns about the increased toxicity in patients due to the drug. They are thinking of restricting the use of Vandetanib to be used in patients with a certain type of rare form of thyroid cancer.

Our Team

Dr. Sunil Sanghi

View all Doctors